FOXP3 and COVID-19: Other theories to explain the decreased amount of this cell subset in COVID-19 are the IL-6 induced transformation of regulatory T cells into Th17 effector cells and the hypoxia-induced degradation of Foxp3 through the activation of the hypoxia-inducible factor-1α (29).